Robert Later, MD
Obstetrics · Sandy, UTNPI 1669567376
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.1% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 28.5% of the total. Reporting peaked in 2024 at $475 and has fallen 66.6% since, to $159 in 2025.
Across 104 payments — averaging $18.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$559
- Astellas Pharma US Inc$352
- Bayer$168
- Currax Pharmaceuticals LLC$126
- Mayne Pharma Commercial LLC$101
- Exeltis, USA Inc.$84
- plus $571 from 18 others
What the payments were for
- Food & beverage$1,82593%
- Education$1357%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 32 | $559 |
| Astellas Pharma US Inc | 14 | $352 |
| Bayer | 8 | $168 |
| Currax Pharmaceuticals LLC | 7 | $126 |
| Mayne Pharma Commercial LLC | 6 | $101 |
| Exeltis, USA Inc. | 5 | $84 |
| Hologic Sales And Service, LLC | 3 | $79 |
| Idorsia Pharmaceuticals US Inc | 3 | $57 |
| Therapeuticsmd, Inc. | 3 | $53 |
| Kowa Pharmaceuticals America, Inc. | 3 | $47 |
| Lupin Inc. | 3 | $44 |
| BD | 2 | $34 |
| Avion Pharmaceuticals | 2 | $33 |
| Shield Therapeutics Inc | 2 | $31 |
| Pfizer | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Biogen | 1 | $23 |
| Meditrina | 1 | $22 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Hologic Inc | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Bausch Health US, LLC | 1 | $14 |
| Virtus Pharmaceuticals LLC | 1 | $12 |
How this compares
Too few obstetrics providers in Utahto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Raloxifene Hcl | 39 | $1,854 |
| Levothyroxine Sodium | 103 | $1,321 |
| ProgesteroneProgesterone, Micronized | 15 | $722 |
| ValacyclovirValacyclovir Hcl | 13 | $644 |
| Bupropion XlBupropion Hcl | 24 | $594 |
| Simvastatin | 43 | $506 |
| Eszopiclone | 21 | $439 |
| Liothyronine Sodium | 12 | $423 |
| Alendronate Sodium | 40 | $382 |
| Spironolactone | 16 | $351 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 20 | $184 |
| Fluoxetine Hcl | 14 | $171 |
| Citalopram HbrCitalopram Hydrobromide | 18 | $158 |
| Atorvastatin Calcium | 20 | $157 |
| Duloxetine Hcl | 13 | $149 |
Paid to pharmacies, not to this prescriber.
Other obstetrics in Sandy
- James PetersonSalt Lake City$11K
- Layne SmithDraper$8K
- Shane ChristensenSalt Lake City$6K
- Gayle StewartSalt Lake City$5K
- Cameron LeavittSt George$3K
- Thomas ConnerSalt Lake City$3K
- Chad LuntSt George$2K
- Douglas AllenPleasant Grove$1K
- Eileen JoyceVernal$1K
- Samuel HeywoodOrem$201
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.